Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity

Summary

The brain is able to change throughout life in response to learning, or injury, or to adapt to changes in the environment, which is known as neuroplasticity. Stroke survivors suffer disabling chronic motor impairments that have proven challenging to improve. Increasing neuroplasticity using selective serotonin reuptake inhibitors (SSRIs) is a promising approach to promote motor recovery in patients with stroke.

Timeline

Start

2020-03-11

Primary completion

2021-02-09

Completion

2021-02-09

Drugs

Indications